SureTrader
Cannabis Stocks News
Interactive Brokers Advertisement
Home > Boards > US Listed > Biotechs > Aurinia Pharmaceuticals Inc (AUPH)

Aurinia Falls On Misinterpreted 'Downgrade'

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
somerssalt Member Profile
 
Followed By 1
Posts 10
Boards Moderated 0
Alias Born 05/03/17
160x600 placeholder
Report of Foreign Issuer (6-k) "Edgar (US Regulatory)" - 9/19/2017 4:10:24 PM
Aurinia to Host R&D Day and Webcast on October 20th in New York, NY "Business Wire" - 9/19/2017 4:01:00 PM
Report of Foreign Issuer (6-k) "Edgar (US Regulatory)" - 9/5/2017 4:07:10 PM
Aurinia to Webcast at Upcoming Investor Conferences "Business Wire" - 9/5/2017 1:05:00 PM
Report of Foreign Issuer (6-k) "Edgar (US Regulatory)" - 8/10/2017 4:37:23 PM
Report of Foreign Issuer (6-k) "Edgar (US Regulatory)" - 8/10/2017 4:31:45 PM
Aurinia Reports Second Quarter 2017 Financial Results, and Provides Operational Highlights "Business Wire" - 8/10/2017 4:30:00 PM
Report of Foreign Issuer (6-k) "Edgar (US Regulatory)" - 7/13/2017 6:03:12 AM
Aurinia Resolves Temporary Non-Compliance with Nasdaq’s Audit Committee Composition Rule "Business Wire" - 7/12/2017 9:15:00 PM
Statement of Ownership (sc 13g) "Edgar (US Regulatory)" - 7/6/2017 6:08:52 AM
Report of Foreign Issuer (6-k) "Edgar (US Regulatory)" - 6/22/2017 4:32:20 PM
Aurinia Announces Results of Annual General Meeting "Business Wire" - 6/22/2017 4:30:00 PM
Aurinia to Host Annual General Meeting of Shareholders and Webcast on June 21 in Vancouver, BC "Business Wire" - 6/21/2017 7:00:00 AM
Report of Foreign Issuer (6-k) "Edgar (US Regulatory)" - 6/16/2017 8:23:17 AM
Voclosporin Remission Data from the Phase IIb AURA-LV Study Highlighted at EULAR 2017 "Business Wire" - 6/16/2017 7:58:00 AM
Technical Snapshots for These Biotech Stocks -- Gilead Sciences, Aurinia Pharma, Esperion Therapeutics, and Alexion Pharma "PR Newswire (US)" - 6/8/2017 6:25:00 AM
Aurinia Presents Additional Data from Phase IIB AURA-LV Study, Demonstrating Stable Renal Function & Blood Pressure without E... "Business Wire" - 6/5/2017 11:27:00 AM
Report of Foreign Issuer (6-k) "Edgar (US Regulatory)" - 6/5/2017 9:18:38 AM
Aurinia Presents Additional Data from Phase Iib Aura-Lv Study, Demonstrating Stable Renal Function & Blood Pressure without E... "Business Wire" - 6/5/2017 8:00:00 AM
Aurinia to Participate in Late Breaking Oral Presentations at Two Upcoming Scientific Conferences "Business Wire" - 5/30/2017 4:19:00 PM
Report of Foreign Issuer (6-k) "Edgar (US Regulatory)" - 5/24/2017 6:06:50 AM
Report of Foreign Issuer (6-k) "Edgar (US Regulatory)" - 5/19/2017 4:37:56 PM
Aurinia Doses First Patient in AURORA Phase 3 Clinical Trial of Voclosporin in Lupus Nephritis "Business Wire" - 5/17/2017 4:02:00 PM
Report of Foreign Issuer (6-k) "Edgar (US Regulatory)" - 5/15/2017 8:02:24 AM
Report of Foreign Issuer (6-k) "Edgar (US Regulatory)" - 5/15/2017 8:01:32 AM
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist